Soligenix
SNGX
#10223
Rank
S$21.05 M
Marketcap
S$2.09
Share price
-1.23%
Change (1 day)
-51.27%
Change (1 year)

Soligenix (SNGX) - P/B ratio

P/B ratio as of December 2025 : 2.18

According to Soligenix's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Soligenix - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-311.76-43.47%
2023-12-313.12-139.4%
2022-12-31-7.91-399.52%
2021-12-312.64-74.14%
2020-12-3110.2-52.83%
2019-12-3121.6793.95%
2018-12-312.42-21.03%
2017-12-313.0785.44%
2016-12-311.65-100.09%
2015-12-31< -10001166.71%
2014-12-31-152663.26%
2013-12-31-20.0-1157.76%
2012-12-311.89109.36%
2011-12-310.9014-83.85%
2010-12-315.58-1.68%
2009-12-315.6883.79%
2008-12-313.09-50.33%
2007-12-316.22-141.77%
2006-12-31-14.9-266.52%
2005-12-318.94-0.84%
2004-12-319.0275.08%
2003-12-315.15118.26%
2002-12-312.36

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Emergent BioSolutions
EBS
1.09-49.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.40-35.87%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
1.59-26.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.15 182.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-0.0229-101.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
3.48 59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.48 105.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel